Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2466074203;74204;74205 chr2:178572154;178572153;178572152chr2:179436881;179436880;179436879
N2AB2301969280;69281;69282 chr2:178572154;178572153;178572152chr2:179436881;179436880;179436879
N2A2209266499;66500;66501 chr2:178572154;178572153;178572152chr2:179436881;179436880;179436879
N2B1559547008;47009;47010 chr2:178572154;178572153;178572152chr2:179436881;179436880;179436879
Novex-11572047383;47384;47385 chr2:178572154;178572153;178572152chr2:179436881;179436880;179436879
Novex-21578747584;47585;47586 chr2:178572154;178572153;178572152chr2:179436881;179436880;179436879
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: AGT
  • RefSeq wild type template codon: TCA
  • Domain: Fn3-67
  • Domain position: 45
  • Structural Position: 60
  • Q(SASA): 0.2321
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/N rs1444695129 None 0.973 N 0.469 0.198 0.203808441222 gnomAD-3.1.2 6.57E-06 None None None None N None 0 0 0 0 0 None 0 0 1.47E-05 0 0
S/N rs1444695129 None 0.973 N 0.469 0.198 0.203808441222 gnomAD-4.0.0 1.23967E-06 None None None None N None 0 0 None 0 0 None 0 1.64528E-04 8.47716E-07 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.0964 likely_benign 0.0931 benign -0.303 Destabilizing 0.366 N 0.411 neutral None None None None N
S/C 0.1242 likely_benign 0.1255 benign -0.198 Destabilizing 0.999 D 0.509 neutral N 0.49945022 None None N
S/D 0.5266 ambiguous 0.4711 ambiguous -0.022 Destabilizing 0.998 D 0.44 neutral None None None None N
S/E 0.6137 likely_pathogenic 0.5781 pathogenic -0.132 Destabilizing 0.982 D 0.424 neutral None None None None N
S/F 0.293 likely_benign 0.2571 benign -0.967 Destabilizing 0.996 D 0.525 neutral None None None None N
S/G 0.0979 likely_benign 0.0956 benign -0.382 Destabilizing 0.982 D 0.391 neutral N 0.503952067 None None N
S/H 0.4432 ambiguous 0.4285 ambiguous -0.89 Destabilizing 1.0 D 0.498 neutral None None None None N
S/I 0.2155 likely_benign 0.195 benign -0.227 Destabilizing 0.989 D 0.485 neutral N 0.49919673 None None N
S/K 0.7352 likely_pathogenic 0.6981 pathogenic -0.428 Destabilizing 0.993 D 0.395 neutral None None None None N
S/L 0.0987 likely_benign 0.0915 benign -0.227 Destabilizing 0.181 N 0.359 neutral None None None None N
S/M 0.1755 likely_benign 0.1721 benign 0.084 Stabilizing 0.996 D 0.485 neutral None None None None N
S/N 0.1433 likely_benign 0.144 benign -0.099 Destabilizing 0.973 D 0.469 neutral N 0.463567197 None None N
S/P 0.7719 likely_pathogenic 0.705 pathogenic -0.226 Destabilizing 0.998 D 0.457 neutral None None None None N
S/Q 0.5435 ambiguous 0.5281 ambiguous -0.407 Destabilizing 0.999 D 0.44 neutral None None None None N
S/R 0.7007 likely_pathogenic 0.6658 pathogenic -0.176 Destabilizing 0.997 D 0.457 neutral N 0.472165252 None None N
S/T 0.0756 likely_benign 0.0741 benign -0.22 Destabilizing 0.626 D 0.419 neutral N 0.457681059 None None N
S/V 0.1998 likely_benign 0.184 benign -0.226 Destabilizing 0.93 D 0.443 neutral None None None None N
S/W 0.4573 ambiguous 0.4162 ambiguous -0.982 Destabilizing 1.0 D 0.698 prob.neutral None None None None N
S/Y 0.2797 likely_benign 0.2599 benign -0.699 Destabilizing 0.998 D 0.554 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.